Research from Eascra Biotech will be onboard Axiom Mission 2 (Ax-2), a private crew mission to the International Space Station set to launch Sunday May 21 ...
8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (...
The cell & gene therapy (CGT) CDMO has an established global footprint with two GMP manufacturing facilities in China and its headquarters in Vancouver...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that the U.S. Food and Drug Administration (FDA) has cleare...
AIDS Healthcare Foundation (AHF), the world’s largest HIV and AIDS healthcare organization, is seeing a reemergence of monkeypox (now known as mpox) ...
Agilent respectfully disagrees with the PTAB’s opinion of unpatentability in view of prior art previously considered by the USPTO during its primary ...
DF-006 is a first-in-class, orally administered ALPK1 agonist immunomodulator that potently stimulates local, innate immunity in the liver, leading to a ro...
“We are thrilled to partner with BeiGene to help people living with CLL in low- and middle-income countries have access to BRUKINSA,” said Pat ...
With more than 80% of its rapidly growing revenues tied to large molecule applications, Wyatt accelerates Waters' ability to build a high-growth business i...
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it has won an injunction in its patent litigation ...
Miso Robotics – the company transforming the restaurant industry with robotics and intelligent automation – announced a new partnership an...
Synthego Corp., a leading provider of genome engineering solutions, has announced a victory in its dispute with Agilent Technologies, Inc., regarding two o...
Agilent Technologies Inc. (NYSE: A) announced that a quarterly dividend of 22.5 cents per share of common stock will be paid on July 26, 2023, ...
Research in MPS IVA led by REGENXBIO scientists moving into clinic Donation of NAV® Technology licenses will support development...
© 2025 Biopharma Boardroom. All Rights Reserved.
